Ammonia is one of the most critical chemical commodities produced and is integral to a number of current industries such as agriculture as well as a key part to future sustainability areas such as clean H2 production. However, the current production methods for ammonia are largely unsustainable and produce large amounts of CO2 emissions. This combined with the current dependence on fossil energy for production has led to researchers attempting to develop a clean and sustainable method for ammonia production. This method involves the thermochemical looping of a nitride compound with H2, and the renitridation of the compound with N2. This thermochemical loop would significantly reduce pressure requirements for ammonia production in addition to only being reliant on renewable inputs. This paper expands and complements this research by detailing the methods for the synthesis of nitride compounds as well as confirming their structure through material characterization. The nitride compounds as well as their oxide precursors were synthesized through Pechini synthesis and co-precipitation, and their structure was confirmed through the use of X-ray diffraction analysis. The XRD patterns of the synthesized nitrides matched those previously synthesized as well as those found in literature. In addition, observation of the spectra for the oxide CoMoO4 showed a marked similarity to that of the oxide precursor for (NixCox)2Mo3N. However, further testing is necessary regarding the phase-purity of synthesized nitrides, as well as the reduction and renitridation capability of nitrides in the line of (NixCox)2Mo3N.

The main scope of this study was to analyze the impact support and identity have on the collegiate athletic career transition process. While student-athletes undergo a variety of transitions, this study focused on the career transition out of collegiate athletics regardless of their reason for leaving or their next steps. The motivation for conducting this research is to take the challenges and recommendations to the next steps and reform the common practice of career transition and provide assistance to athletes facing adversity in this position. A study on 32 voluntary student-athletes in different phases of the transition process ranging from current student-athletes to graduated student-athletes years detached from their sport was conducted via electronic questionnaire. Questions about demographics and their personal experiences relating to identity, support, and transition as a whole were asked regarding their time as student-athletes through their transition (if applicable). Through analyzing the responses and previous literature, it is evident that support is necessary from the early stages as a student-athlete through their transition out of the sport to minimize the negative impact. It is also apparent that one's athletic identity is established early on in their career and is difficult to dissociate from to rediscover a personal identity not connected to athletic performance. Knowing what we do now, there are limitations in the findings such as within the demographics, questionnaire, and clarity. This would be beneficial to research and study further to optimize a solution to assist in the athletic career transition process and alleviate additional barriers athletes face when no longer having their sport.

Aminoglycosides contain a basic unit of an amino-modified glycoside (sugar) and have potent antibacterial properties used to treat a wide range of bacterial infections, including those that occur in the soft tissue, chest, urinary tract, and endocardial tissue.1, 2 With a broad spectrum of activity and convenient dosing schedule, Aminoglycoside helps to effectively fight off Gram-negative bacteria.1, 3 In 1944 an aminoglycoside called streptomycin entered clinical trials to test its effectiveness as an antibiotic.4 After several years other classes of aminoglycosides were discovered such as neomycin, gentamicin, kanamycin, and netilmicin.4 When introduced these antibiotics presented major clinical advancements in the treatment of Tuberculosis and other bacterial infections.3, 4 However their use in modern medicine has diminished due to their toxicity, required parenteral delivery, and the availability of alternative antibiotics.3, 5 The dose-dependent toxicity of aminoglycosides limits their use due to a narrow range of safe aminoglycoside plasma concentrations.3, 5 Exceeding this range in non-target tissues can lead to negative effects on the audio-vestibular apparatus and kidneys.3, 5, 6 In the 1980’s, clinicians began treating infections with antibiotics that were perceived as less toxic and providing broader antibacterial activity.7 This resulted in aminoglycosides being prescribed for more persistent infections that were resistant to other antibiotics.3 With the amount of antibiotic resistant bacteria increasing, many scientists have begun looking into methods for minimizing aminoglycoside toxicity and maximizing its antibacterial activity.3, 8 These methods include encapsulation and polymer conjugation.9, 10 By encapsulating aminoglycosides in liposomes or other vesicles scientists aim to increase its concentration in infected tissues while decreasing nephro- and ototoxicity.9 With conjugated polymers scientists have created polymer complexes containing aminoglycosides and other compounds such as dopamine.11 The goal of these polymers is to limit toxicity by slowing antibiotic release and increasing efficacy of the antibiotic through targeted delivery and toxicity of other compounds.9, 10, 11 Other than its use in treating infections, aminoglycosides are gaining attention as an excellent vehicle for gene delivery.12 In this application aminoglycosides are used to correct a genetic defect by introducing a normal copy of the gene into affected cells.12,13 Currently scientists are assessing aminoglycosides for gene therapy in the treatment of cancer and various other diseases.12, 14 This review will focus on the diverse customizability of aminoglycosides in treating infections and as vehicles for gene therapy.